{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:02:46Z","timestamp":1778090566522,"version":"3.51.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LEO Pharma S.A."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232146","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T19:02:33Z","timestamp":1589569353000},"page":"e0232146","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of differentially expressed genes in actinic keratosis samples treated with ingenol mebutate gel"],"prefix":"10.1371","volume":"15","author":[{"given":"Sonia","family":"Segura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gadea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Nonell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyn","family":"Andrades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Hern\u00e1ndez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-0076","authenticated-orcid":true,"given":"Agust\u00ed","family":"Toll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"pone.0232146.ref001","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"RN Werner","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"pone.0232146.ref002","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3315\/jdcr.2015.1199","article-title":"How to treat actinic keratosis? An update","volume":"9","author":"C Costa","year":"2015","journal-title":"J Dermatol Case Rep"},{"issue":"1 Pt 2","key":"pone.0232146.ref003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease","volume":"42","author":"RG Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"pone.0232146.ref004","first-page":"335","article-title":"Actinic keratosis: how to differentiate the good from the bad ones?","volume":"16","author":"PJ Quaedvlieg","year":"2006","journal-title":"Eur J Dermatol"},{"key":"pone.0232146.ref005","first-page":"1099","article-title":"The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma","volume":"33","author":"A Fuchs","year":"2007","journal-title":"Dermatol Surg"},{"key":"pone.0232146.ref006","first-page":"w14026","article-title":"Swiss clinical practice guidelines on field cancerization of the skin","volume":"144","author":"G Hofbauer","year":"2014","journal-title":"Swiss Med Wkly"},{"issue":"2","key":"pone.0232146.ref007","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","article-title":"From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma","volume":"122","author":"V Ratushny","year":"2012","journal-title":"J Clin Invest"},{"key":"pone.0232146.ref008","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","article-title":"Epidemiology of actinic keratoses and squamous cell carcinoma","volume":"42","author":"SJ Salasche","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"pone.0232146.ref009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13555-014-0049-y","article-title":"Actinic keratosis: rationale and management","volume":"4","author":"A Dodds","year":"2014","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"Suppl 5","key":"pone.0232146.ref010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdv.14375","article-title":"New and current preventive treatment options in actinic keratosis","volume":"31","author":"P Arenberger","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"pone.0232146.ref011","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2147\/TCRM.S145779","article-title":"Clinical utility of ingenol mebutate in the management of actinic keratosis: perspectives from clinical practice","volume":"14","author":"N Skroza","year":"2018","journal-title":"Ther Clin Risk Manag"},{"issue":"Suppl 5","key":"pone.0232146.ref012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdv.14375","article-title":"New and current preventive treatment options in actinic keratosis","volume":"31","author":"P Arenberger","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"pone.0232146.ref013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1358\/dot.2013.49.1.1910723","article-title":"Ingenol mebutate: a new option for actinic keratosis treatment","volume":"49","author":"J Gras","year":"2013","journal-title":"Drugs Today (Barc)Jan"},{"issue":"12","key":"pone.0232146.ref014","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1517\/14740338.2015.1108962","article-title":"Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis","volume":"14","author":"B Berman","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"5 Pt 1","key":"pone.0232146.ref015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0190-9622(91)70113-G","article-title":"A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck","volume":"24","author":"EA Olsen","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"pone.0232146.ref016","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"M Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0232146.ref017","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.clindermatol.2013.05.028","article-title":"Morphologic grading and treatment of facial actinic keratosis","volume":"32","author":"I Zalaudek","year":"2014","journal-title":"Clin Dermatol"},{"issue":"3","key":"pone.0232146.ref018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1747.1999.00690.x","article-title":"In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology","volume":"113","author":"M Rajadhyaksha","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"11","key":"pone.0232146.ref019","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/jdv.13211","article-title":"A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body","volume":"29","author":"G Pellacani","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"pone.0232146.ref020","volume-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2012"},{"issue":"4","key":"pone.0232146.ref021","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"RA Irizarry","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"pone.0232146.ref022","volume-title":"aroma.affymetrix: A generic framework in R for analyzing small to very large Affymetrix data sets in bounded memory, Tech Report #745","author":"H. Bengtsson","year":"2008"},{"issue":"7","key":"pone.0232146.ref023","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0232146.ref024","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Yoav Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society. Series B (Methodological)"},{"key":"pone.0232146.ref025","unstructured":"Conesa A, Nueda MJ. 2017maSigPro: significant gene expression profile differences in time course gene expression data. R package version 1.52.0. (available at: http:\/\/bioinfo.cipf.es\/)."},{"key":"pone.0232146.ref026","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"Bork P and Snel B: STRING: A database of predicted functional associations between proteins","volume":"31","author":"C von Mering","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"pone.0232146.ref027","doi-asserted-by":"crossref","first-page":"D808","DOI":"10.1093\/nar\/gks1094","article-title":"STRING v9.1: protein-protein interaction networks, with increased coverage and integration","volume":"41","author":"A Franceschini","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"pone.0232146.ref028","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: Tool for the unification of biology","volume":"25","author":"M Ashburner","year":"2000","journal-title":"Nat Genet"},{"key":"pone.0232146.ref029","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: a database of reactions, pathways and biological processes","volume":"39","author":"D Croft","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"pone.0232146.ref030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"},{"issue":"1 Suppl 1","key":"pone.0232146.ref031","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jaad.2012.09.053","article-title":"Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation","volume":"68","author":"B Berman","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"pone.0232146.ref032","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0923-1811(01)00124-4","article-title":"Expression profiling of cancer-related genes in human keratinocytes following non-lethal ultraviolet B irradiation","volume":"27","author":"T Murakami","year":"2001","journal-title":"J Dermatol Sci"},{"issue":"1","key":"pone.0232146.ref033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13555-014-0049-y","article-title":"Actinic keratosis: rationale and management","volume":"4","author":"A Dodds","year":"2014","journal-title":"Dermatol Ther (Heidelb)"},{"key":"pone.0232146.ref034","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/jdv.13179","article-title":"Methods and Results Report\u2014Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum","volume":"29","author":"RN Werner","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"pone.0232146.ref035","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jaad.2012.09.050","article-title":"Clinical findings using ingenol mebutate gel to treat actinic keratoses","volume":"68","author":"G Martin","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"1 Suppl 1","key":"pone.0232146.ref036","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jaad.2012.09.050","article-title":"Clinical findings using ingenol mebutate gel to treat actinic keratoses","volume":"68","author":"G Martin","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"pone.0232146.ref037","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5306\/wjco.v8.i5.405","article-title":"Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp","volume":"8","author":"N Skroza","year":"2017","journal-title":"World J Clin Oncol"},{"issue":"2","key":"pone.0232146.ref038","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13555-014-0059-9","article-title":"A new, objective, quantitative scale for measuring local skin responses following topical actinic keratosis therapy with ingenol mebutate","volume":"4","author":"R Rosen","year":"2014","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"pone.0232146.ref039","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/bjd.14517","article-title":"In vivo confocal microscopy efficacy assessment of daylight photodynamic therapy in actinic keratosis patients","volume":"175","author":"SM Seyed Jafari","year":"2016","journal-title":"Br J Dermatol"},{"issue":"8","key":"pone.0232146.ref040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/omi.2012.0083","article-title":"Redundancy control in pathway databases (ReCiPa): an application for improving gene-set enrichment analysis in Omics studies and \"Big data\" biology","volume":"17","author":"JC Vivar","year":"2013","journal-title":"OMICS"},{"key":"pone.0232146.ref041","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ebiom.2016.06.011","article-title":"A Mouse Model of Hyperproliferative Human Epithelium Validated by Keratin Profiling Shows an Aberrant Cytoskeletal Response to Injury","volume":"9","author":"S Zhussupbekova","year":"2016","journal-title":"EBioMedicineJul"},{"key":"pone.0232146.ref042","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2407-13-58","article-title":"Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients","volume":"13","author":"L Hameetman","year":"2013","journal-title":"BMC Cancer"},{"issue":"6","key":"pone.0232146.ref043","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1365-2133.2007.08218.x","article-title":"Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod","volume":"157","author":"A Torres","year":"2007","journal-title":"Br J Dermatol"},{"issue":"9","key":"pone.0232146.ref044","doi-asserted-by":"crossref","first-page":"e0160096","DOI":"10.1371\/journal.pone.0160096","article-title":"Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate","volume":"11","author":"S Emmert","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"pone.0232146.ref045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0022-202X.2004.22719.x","article-title":"S100 proteins in the epidermis","volume":"123","author":"RL Eckert","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"2","key":"pone.0232146.ref046","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.autrev.2009.03.011","article-title":"SERPINB3, apoptosis and autoimmunity","volume":"9","author":"L Vidalino","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"1","key":"pone.0232146.ref047","doi-asserted-by":"crossref","first-page":"a015370","DOI":"10.1101\/cshperspect.a015370","article-title":"Natural and sun-induced aging of human skin","volume":"5","author":"L Ritti\u00e9","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 2","key":"pone.0232146.ref048","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1093\/geront\/gnw003","article-title":"Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options","volume":"56","author":"U Blume-Peytavi","year":"2016","journal-title":"Gerontologist"},{"issue":"6","key":"pone.0232146.ref049","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jaad.2018.05.1244","article-title":"Anti-aging effects of ingenol mebutate for patients with actinic keratosis","volume":"79","author":"M Kim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"pone.0232146.ref050","first-page":"1565","article-title":"Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas","volume":"23","author":"T Rost","year":"2003","journal-title":"Anticancer Res"},{"issue":"5","key":"pone.0232146.ref051","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1541-7786.257.2.5","article-title":"Human tissue kallikreins: physiologic roles and applications in cancer","volume":"2","author":"CA Borgo\u00f1o","year":"2004","journal-title":"Mol Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T21:19:11Z","timestamp":1666559951000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232146"}},"subtitle":[],"editor":[{"given":"Liang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232146","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,15]]}}}